Phibro Animal Health (PHIB) Surges on Q2 Results, Raises FY26 Revenue Guidance

Phibro Animal Health (PHIB) shares jumped on strong second-quarter results and a revised revenue outlook. The company reported Q2 revenue of $312 million, a 12% increase from $279 million in the same period last year, driven by higher sales in its equine and companion animal segments. Management raised full-year 2026 revenue guidance to a range of $1.18B-$1.22B from $1.12B-$1.16B, citing improved demand and pricing. The stock closed at $47.25, up 14.5% on the day.